Gt Biopharma Inc
GTBP
$1.485+0.14 (+10.82%)
Aug 18, 2025, 4:00 PM
Financials
| 52Week High | 4.10 | 52Week Low | 0.96 |
| Beta | 1.34 | Current Ratio Annual | 0.72 |
| Current Ratio Quarterly | 0.73 | Gross Margin TTM | 36.51 |
| Market Cap | 5.28M | Net Profit Margin TTM | -26,209.52 |
| Operating Margin TTM | -8,623.81 | Price To Book | 2.52 |
| Price To Free Cash Flow TTM | 480.26 | Price To Sales TTM | 83.86 |
| Quick Ratio Annual | 0.69 | Quick Ratio Quarterly | 0.68 |
| Return On Assets TTM | -203.74 | Return On Equity TTM | -242.22 |
| Return On Investment TTM | -242.22 | Revenue Per Share TTM | 0.00 |
13F Aggregates
| Quarter | Funds | Added | Exited | Increased | Decreased | Unchanged | Shares | Value |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 20 | 0 | 0 | 1 | 0 | 1 | 1.29M | $308.08K |
| Mar 31, 2025 | 21(+5%) | 3(+%) | 2(+%) | 2(+100%) | 5(+%) | 10(+900%) | 99.69K(-92%) | $220.50K(-28%) |
| Jun 30, 2025 | 20(-5%) | 4(+33%) | 3(+50%) | 5(+150%) | 3(-40%) | 7(-30%) | 183.16K(+84%) | $654.32K(+197%) |